(1)
Survival Rate of Gemcitabine Monotherapy After Prior Platinum-Based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran 2022, 49 (12), 693-701. https://doi.org/10.55175/cdk.v49i12.329.